Abstract
The DNA-binding of three chemical carcinogens, benzo(a)pyrene (BP), aflatoxin B1 (AFB) and 2-acetylaminofluorene (AAF) subsequent to their metabolic activation by explant cultures of human bladder and bronchus, tissues has been studied. The tissue specimens, obtained at autopsy, were cultured in serum free medium in a rocking culture system under an atmosphere of 50% 02 — 47% N2 — 3% C02. The epithelial cell DNA binding levels were determined 24 hours following the addition of 1 μM of the tritium labeled hydrocarbon and isolation of the DNA by hydroxylapatite chromatography. Following hydrolysis of the purified DNA, the carcinogen-DNA adducts were analyzed via high pressure liquid chromatography (HPLC). The BP-DNA adducts obtained from both tissues co-chromatographed with adduct standards formed by the reactions of 7,8-dihydroxy-7,8,9,10-tetra- hydrobenzo(a)pyrene at the exocyclic amino nitrogen (N2) of guanine. The AFB-DNA adducts co-chromatographed with adducts found in rat liver in vivo and formed by the attack of 8,9-dihydro-8,9-oxyaflatoxin Bi at the N7 position of guanine. The range of DNA binding inter- individual variation was higher in the bladder than in the bronchus for all three chemicals. Further, weak but significant, correlations between the carcinogen-DNA binding level in explants of the two tissues from the same individual was observed for all three carcinogens. For both human bladder and bronchus there was a significant correlation between BP and AAF DNA binding levels in tissues from the same individual whereas no such significant correlation existed between BP and AFB DNA binding levels. The utility of the explant culture method for measuring interindividual variation with respect to genotoxin metabolism is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. R. Idle and R. L. Smith, Polymorphisms of Carbon Centers of Drugs and Their Clinical Significance, Drug Metabol. Rev., 9: 301–317 (1979).
E. S. Vesell, Pharmacogenetics, Biochem. Pharmacol., 24: 445–450 (1975).
O. Pelkonen, E. Sotaniemi, and R. Mokka, The In vitro Oxidative Metabolism of Benzo(a)pyrene in Human Liver Measured by Different Assays, Chem. Biol. Interactions, 16: 13–21 (1977).
N. Sabadie, C. Malaveille, A. M. Campus, and H. Bartsch, Com¬parison of the Hydroxylation of Benzo(a)pyrene with the Metabolism of Vinyl Chloride, N-Nitrosomorphine and N-Nitroso-N’- Methylpiperazine to Mutagens by Human and Rat Liver Microsomal Fractions, Cancer Res., 40: 119–26 (1980).
M. W. Kahng, M. W. Smith, and B. F. Trump, Aryl Hydrocarbon Hydroxylase in Human Bronchial Epithelium and Blood Monocyte, J. Natl. Cancer Inst., 66: 222–232 (1981).
C. C. Harris, B. F. Trump, R. Grafstrom, and H. Autrup, Differ¬ences in Metabolism of Chemical Carcinogens in Cultured Human Epithelial Tissues and Cells, in: Mechanisms in Chemical Carcinogenesis (C. C. Harris and P. Cerutti, eds.), A. L. Liss Publishing Co., Inc., New York, pp. 289–298 (1983).
G. D. Stoner, F. B. Daniel, K. M. Schenck, H. A. J. Schut, P. J. Goldblatt, and D. W. Sandwisch, Metabolism and DNA Bind¬ing of Benzo(a)pyrene in Cultured Human Bladder and Bronchus, Carcinogenesis, 3: 195–201 (1982).
J, Remsen, D. Jerina, H. Yagi, and P. Cerutti, In vitro Reaction of Radioactive 73,83-Dihydroxy-9a,10a-epoxy-7,8,9-tetra- hydrobenzo(a)pyrene and 73,8a-Dihydroxy-93,103-epoxy-7,8,9,10- tetrahydrobenzo(a)pyrene with DNA, Biochem. Biophys. Res. Comm., 74: 934–940 (1977).
H. Autrup, A. M. Jeffrey, and C. C. Harris, Metabolism of Benzo(a)pyrene in Cultured Human Bronchus, Trachea, Colon, and Esophagus, in: Polynuclear ARomatic Hydrocarbons: Chemistry and Biological Effects (A. Bjorseth and A. J. Dennis, eds.), pp. 89–105, Battelle Press, Columbus, Ohio (1980).
H. Autrup, R. C. Grafstrom, M. Brugh, J. F. Lechner, A. Haugen, B. F. Trump, and C. C. Harris, Comparison of Benzo(a)pyrene Metabolism in Bronchus, Esophagus, Colon, and Duodenum from the Same Individual, Cancer Res., 42: 934–1938 (1982).
F. B. Daniel, H. A. J. Schut, G. D. Stoner, D. W. Sandwisch, K. M. Schenck, C. A. Hoffman, and J. R. Patrick, Interspecies Comparisons of Benzo(a)pyrene Metabolism and DNA-Adduct Forma¬tion in Cultured Human and Animal Model Bladder and Tracheo¬bronchial Tissues, Cancer Res., 43: 4723–4729 (1983).
H. Autrup, F. C. Wefald, A. M. Jeffrey, H. Tate, R. D. Schwartz, B. F. Trump, and C. C. Harris, Metabolism of Benzo(a)pyrene by Cultured Tracheobronchial Tissues from Mice, Rats, Hamsters, Bovines, and Humans, Int. J. Cancer, 25: 293–300 (1980).
H. Autrup, C. C. Harris, B. F. Trump, and A. M. Jeffrey, Metab¬olism of Benzo(a)pyrene and Identification of the Major Benzo- (a)pyrene-DNA Adducts in Cultured Human Colon, Cancer Res., 38: 3689–3696 (1978).
R. G. Croy, J. M. Essigmann, V. N. Reinhold, and G. N. Wogan, Identification of the Principal Aflatoxin Bx-DNA Adduct Formed In vitro in Rat Liver, Proc. Natl. Acad. Sci., U.S.A., 75: 1745–1749 (1978).
J. M. Essigmann, R. G. Croy, A. M. Nadzan, W. F. Busby, Jr., V. N. Reinhold, G. Buchi, and G. N. Wogan, Structural Identification of the Major DNA Adduct Formed by Aflatoxin Bi In vitro, Proc. Natl. Acad. Sci., U.S.A., 74: 1870–1874 (1977).
T. V. Wang and P. Cerutti, Spontaneous Reaction of Aflatoxin Bi Modified Deoxyribonucleic Acid In vitro, Biochemistry, 19: 1692–1698 (1980).
H. Autrup, J. M. Essigmann, R. G. Croy, B. F. Trump, G. N. Wogan, and C. C. Harris, Metabolism of Aflatoxin Bx and Iden¬tification of the Major Aflatoxin Bi-DNA Adducts Formed in Cultured Human Bronchus and Colon, Cancer Res., 39: 694–698 (1979).
H. Autrup, R. D. Schwartz, J. M. Essigmann, L. Smith, B. F. Trump, and C. C. Harris, Metabolism of Aflatoxin Bi, Benzo(a)- pyrene, and 1,2-Dimethylhydrazine by Cultured Rat and Human Colon, Tetato. Carcino. Muta., 1: 3–13 (1980).
P.J. Hertzog, J. R. Lindsay-Smith, and R. C. Garner, A High Pressure Liquid Chromatography Study on the Removal of DNA- Bound Aflatoxin Bx in Rat Liver and In vitro, Carcinogenesis, 1: 787–793 (1980).
T. V. Wang and P. A. Cerutti, Formation and Removal of Aflatoxin Bi-Induced DNA Lesions in Epithelioid Human Lung Cells, Cancer Res., 39: 5165–5170 (1979).
S. A. Leadon, R. M. Tyrrell, and P. A. Cerutti, Excision Repair of Aflatoxin Bi-DNA Adducts in Human Fibroblasts, Cancer Res., 41: 5125 - 5129 (1981).
L. A. Barrett, E. M. McDowell, A. L. Frank, C. C. Harris, and B. F. Trump, Long-Term Organ Culture of Human Bronchial Epithelium, Cancer Res., 36: 1003 - 1006 (1976).
G. D. Stoner, Y. Katoh, J. M. Foidart, G. A. Meyers, and C. C. Harris, Identification and Culture of Human Bronchial Epithelial Cells, in: Methods in Cell Biology XXI A (C. C. Harris, B. F. Trump, G. D. Stoner, eds.), Academic Press, New York, pp. 15–35 (1980).
C. C. Harris, H. Autrup, G. D. Stoner, B. F. Trump, E. Hillman, P. W. Schafer, and A. M. Jeffrey, Metabolism of Benzo(a)pyrene, N-Nitrosodimethylamine and N-Nitrosopyrrolidine and Identification of the Major Carcinogen-DNA Adducts Formed in Cultured Human Esophagus, Cancer Res., 39: 4401–4406 (1979).
P. Brookes, Covalent Interaction of Carcinogens with DNA, Life Sciences, 16: 331–344 (1975).
W. K. Lutz, In vivo Covalent Binding of Organic Chemicals to DNA as a Quantitative Indicator in the Process of Chemical Carcinogenesis, Mutation Res., 65: 289–356 (1979).
C. C. Harris, H. Autrup, R. Connor, L. A. Barrett, E. M. McDowell, and B. F. Trump, Interindividual Variation in Binding of Benzo(a)pyrene to DNA in Cultured Human Bronchi, Science, 194: 1067–1069 (1976).
C. C. Harris, H. Autrup, G. D. Stoner, S. K. Yang, J. C. Leutz, H. V. Gelboin, J. K. Selkirk, R. J. Connor, L. A. Barrett,R. T. Jones, E. McDowell, and B. F. Trump, Metabolism of Benzo- (a)pyrene and 7,12-Dimethylbenz(a)anthracene in Cultured Human Bronchus and Pancreatic Duct, Cancer Res., 37: 3349–3355 (1977).
B. P. Moore, R. M. Hicks, M. A. Knowles, and S. Redgrave, Metabolism and Binding of Benzo(a)pyrene and 2-Acetylamino- fluorene by Short-Term Organ Cultures of Human and Rat Bladder, Cancer Res., 42: 642–648 (1982).
U.S. Public Health Service, The Consequences of Smoking, U.S. Department of Health, Education, and Welfare, Public Health Service, Washington, D.C., DHEW Publ. No. (HSM) 71–7513 (1971); (HSM) 73-8704 (1974); and (CDS) 76–8704 (1976).
P. Cole, R. R. Morrison, H. Haring, and G. M. Friedel, Smoking and Cancer of the Lower Urinary Tract, N. Engl. J. Med., 284: 129–134 (1971).
E. Wynder and D. Hoffman, Experimental Tobacco Carcinogenesis, Science, 162: 862–871 (1968).
G. N. Wogan, Aflatoxin Carcinogenesis, in: Methods in Cancer Res. (H. Busch, ed.), 7:309–444 (1974).
F. G. Peers and C. A. Linsell, Dietary Aflatoxins and Liver Cancer - A Population Based Study in Kenya, Br. J. Cancer, 27: 473–484 (1973).
R. C. Shank, N. Bharmaropravoti, J. E. Gordon, and G. N. Wogan, Dietary Aflatoxin and Human Liver Cancer in Two Municipal Populations of Thailand, Fd. Cosmet. Toxicol., 10: 171 - 179 (1972).
G. N. Wogan, S. Paglvalunga, and P. M. Newberne, Carcinogenic Effect of Low Dietary Levels of Aflatoxin Bx in Rats, Fd. Cosmet. Toxicol., 12(681–687 (1971).
C. Gopalon, P. G. Tupule, and D. Krishnamuthi, Induction of Hepatic Carcinoma and Aflatoxin in the Rhesus Monkey, Fd. Cosmet. Toxicol., 10: 519–521 (1972).
R. H. Adamson, P. Correa, S. Sieber, K. R. Mclntire, and D. W. Dalgard, Carcinogenicity of Aflatoxin Bi in Rhesus Monkey: Two Cases of Primary Liver Cancer, J. Natl. Cancer Inst., 57: 67–78 (1976).
S. C. Booth, H. Bosenberg, R. G. Garner, P. J. Hertzog, and K. Norpoth, The Activation of Aflatoxin Bx in Liver Slices and in Bacterial Mutagenicity Assays Using Livers from Different Species Including Man, Carcinogenesis, 2: 1063–1068 (1981).
G. D. Stoner, F. B. Daniel, K. M. Schenck, H. A. J. Schut,D. W. Sandwisch, A. F. Gohara, DNA Binding and Adduct Formation of Aflatoxin Bx in Cultured Human and Animal Tracheobronchial and Bladder Tissues, Carcinogenesis, 3: 1345–1348 (1982).
D. B. Clayson, in: The Biology and Clinical Management of Bladder Cancer (E. H. Cooper and R. E. Williams, eds.), Black- well Scientific Publications, London, pp. 1–35 (1975).
W. F. Dunning, M. R. Curtis, and M. E. Maun, The Effect of Dietary Tryptophan and the Occurrence of 2-Acetylaminofluorene- Induced Liver and Bladder Cancer in Rats, Cancer Res., 10: 454–459 (1950).
M. Wood, Factors Influencing the Induction of Tumors of the Urinary Bladder and Liver by 2-Acetylaminofluorene in the Mouse, Europ. J. Cancer, 5: 41–47 (1969).
D. B. Clayson and R. C. Garner, in: Chemical Carcinogens ( C. E. Searle, ed.), American Chemical Society, Washington, D.C. (1976).
R. A. M. Case, M. E. Hosker, D. B. McDonald, and T. J. Pearson, Tumor of the Urinary Bladder in Workmen Engaged in the Manu¬facture and Use of Certain Dyestuff. Intermediates in the British Chemical Industry. The role of Aniline, Benzidine, Alpha-Naphtylamine and Beta-Naphtylamine, Br. J. Ind. Med., 11: 75–104 (1954).
IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 4, International Agency for Research on Cancer, Lyon, pp. 3–127 (1974).
F. B. Daniel, G. D. Stoner, and H. A. J. Schut, Unpublished Observations (1982).
G. D. Stoner, C. C. Harris, H. Autrup, B. F. Trump, E. W. Kingsbury, and G. A. Meyers, Explant Culture of Human Peripheral Lung, I. Metabolism of Benzo(a)pyrene, Lab. Invest., 38: 685–692 (1978).
H. Autrup, C. C. Harris, G. D. Stoner, J. K. Selkirk, P. W. Schafer, and B. F. Trump, Metabolism of [3H]Benzo(a)pyrene by Cultured Human Bronchus and Cultured Pulmonary Alveolar Macrophages, Lab. Invest., 38: 217–224 (1978).
G. M. Cohen, R. Mehta, and M. Merdith-Brown, Large Interin- dividual Variations in Metabolism of Benzo(a)pyrene by Peripheral Lung Tissue from Lung Cancer Patients, Int. J. Cancer, 24: 129–133 (1979).
H. L. Gurtoo and L. V. Dave, In vitro Metabolic Conversion of Aflatoxins and Benzo(a)pyrene to Nucleic Acid-Binding Metabolites, Cancer Res., 35:382–389 (1975).
C. C. Harris, H. Autrup, G. D. Stoner, E. M. McDowell, B. F. Trump, and P. Schafer, Metabolism of Dimethylnitrosamine and 1,2-Dimethylhydrazine in Cultured Human Bronchi, Cancer Res., 37: 2309–2311 (1977).
R. W. Pero, C. Bryngelsson, F. Mitelman, T. Thulin, and A. Nordon, High Blood Pressure Related to Carcinogen-Induced Unscheduled DNA Synthesis, DNA Carcinogen Binding and Chromosomal Aberrations in Human Lymphocytes, Proc. Natl. Acad. Sci., U.S.A., 73: 2496–2500 (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Daniel, F.B., Stoner, G.D., Schut, H.A.J. (1984). Interindividual Variation in the DNA Binding of Chemical Genotoxins Following Metabolism by Human Bladder and Bronchus Explants. In: de Serres, F.J., Pero, R.W. (eds) Individual Susceptibility to Genotoxic Agents in the Human Population. Environmental Science Research, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2765-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2765-3_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9709-3
Online ISBN: 978-1-4613-2765-3
eBook Packages: Springer Book Archive